Hypocalcemia and Graves' disease associated with 22q11.2 deletion syndrome

Pediatrics InternationalVolume 65, Issue 1 e15709 CLINICAL NOTE Hypocalcemia and Graves' disease associated with 22q11.2 deletion syndrome Wataru Tanaka, Wataru Tanaka Department of Endocrinology and Metabolism, Fukuoka Children's Hospital, Fukuoka, JapanSearch for more papers by this authorNoriko Oyama, Corresponding Author Noriko Oyama [email protected] orcid.org/0000-0002-4839-0699 Department of Endocrinology and Metabolism, Fukuoka Children's Hospital, Fukuoka, Japan Department of Pediatrics, Oita Prefectural Hospital, Oita, Japan Correspondence Noriko Oyama, Department of Pediatrics, Oita Prefectural Hospital, 2-8-1 Bunyou, Oita 870-0855, Japan. Email: [email protected]Search for more papers by this authorMika Makimura, Mika Makimura Department of Endocrinology and Metabolism, Fukuoka Children's Hospital, Fukuoka, JapanSearch for more papers by this authorKenichi Miyako, Kenichi Miyako Department of Endocrinology and Metabolism, Fukuoka Children's Hospital, Fukuoka, JapanSearch for more papers by this author Wataru Tanaka, Wataru Tanaka Department of Endocrinology and Metabolism, Fukuoka Children's Hospital, Fukuoka, JapanSearch for more papers by this authorNoriko Oyama, Corresponding Author Noriko Oyama [email protected] orcid.org/0000-0002-4839-0699 Department of Endocrinology and Metabolism, Fukuoka Children's Hospital, Fukuoka, Japan Department of Pediatrics, Oita Prefectural Hospital, Oita, Japan Correspondence Noriko Oyama, Department of Pediatrics, Oita Prefectural Hospital, 2-8-1 Bunyou, Oita 870-0855, Japan. Email: [email protected]Search for more papers by this authorMika Makimura, Mika Makimura Department of Endocrinology and Metabolism, Fukuoka Children's Hospital, Fukuoka, JapanSearch for more papers by this authorKenichi Miyako, Kenichi Miyako Department of Endocrinology and Metabolism, Fukuoka Children's Hospital, Fukuoka, JapanSearch for more papers by this author First published: 15 November 2023 https://doi.org/10.1111/ped.15709Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest. REFERENCES 1McDonald-McGinn DM, Sullivan KE, Marino B, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers. 2015; 1:15071. 2Shugar AL, Shapiro JM, Cytrynbaum C, Hedges S, Weksberg R, Fishman L. An increased prevalence of thyroid disease in children with 22q11.2 deletion syndrome. Am J Med Genet A. 2015; 167: 1560–1564. 3Casto C, Pepe G, Li Pomi A, Corica D, Aversa T, Wasniewska M. Hashimoto's thyroiditis and Graves' disease in genetic syndromes in pediatric age. Genes. 2021; 12: 222. 4Nicholls JJ, Brassill MJ, Williams GR, Bassett JH. The skeletal consequences of thyrotoxicosis. J Endocrinol. 2012; 213: 209–221. 5Cheung EN, George SR, Costain GA, et al. Prevalence of hypocalcaemia and its associated features in 22q11·2 deletion syndrome. Clin Endocrinol. 2014; 81: 190–196. Volume65, Issue1January/December 2023e15709 ReferencesRelatedInformation